Artificial intelligence (AI) software developer Annalise.ai said the latest version of its CT brain scan software is available for clinical use in Australia, New Zealand, and the U.K.
The company's Enterprise CTB software-as-a-medical device (SaMD) decision-support software is designed for noncontrast CT brain studies. The algorithm can identify 130 imaging findings, including a wide range of conditions that require time-sensitive interventions, the company said.
Annalise CTB is designed to be an assistive clinical tool to empower radiologists with a "second pair of eyes" to help them improve diagnostic accuracy and health outcomes for patients, Annialise.ai added.
